Birmingham, West Midlands -- (SBWIRE) -- 10/01/2013 -- Value Penny Stocks issues special report on AMARANTUS BIOSCIENCE HOLDINGS, INC.(OTCBB:AMBS), First Liberty Power Corp(OTCMKTS:FLPC),diaDexus, Inc.(OTCMKTS:DDXS), Affymax, Inc.(OTCMKTS:AFFY)
AMARANTUS BIOSCIENCE HOLDINGS, INC.(OTCBB:AMBS) managed to keep its gain at 0.80% on above-normal volume of 3.03 million shares. The stock settled at $0.063 after floating in a range of $0.0622to $0.67. Its latest price was $0.063, reaching market capitalization of $29.04million. Its 52-week range has been $0.01 to $0.20. Amarantus BioScience Holdings, Inc., a development-stage biotechnology company, focuses on the discovery and development of drug candidates and diagnostic blood tests to diagnose and treat human diseases in the United States.
What was the Moving Force behind AMBS On Bullish Run? Read This Research Report on AMBS
First Liberty Power Corp(OTCMKTS:FLPC) traded down on a volume of 3.91 million, lower than its standard daily volume. Shares have dropped -3.95% to $0.0164. Over the last twelve months, the stock has lost -51.04% and faced a worst price of $0.02. First Liberty Power Corp., a mineral exploration company, engages in the exploration, development, mining, and refining of strategic industrial metals in the United States. Its primary target elements include lithium, antimony, vanadium, uranium, and graphite.
Has FLPC Found The Bottom And Ready To Gain Momentum? Find Out Here
diaDexus, Inc.(OTCMKTS:DDXS) settled +1.68% higher at $1.82 on below-normal volume of 263,267.00 shares during the last trading day. The stock has its 12-month high at $1.95 and 52-week low price was $0.028. It traded in a range of $1.82 to $1.91during the last trading day. diaDexus, Inc., a life sciences company, focuses on the development and commercialization of proprietary cardiovascular diagnostic products addressing needs in cardiovascular disease.
For How Long DDXS Gloss will Attract Investors? Find out via this report
Affymax, Inc.(OTCMKTS:AFFY) saw its price fall on below-normal volume, as 285,623.00 shares changed hands when compared with its average daily volume of 833,772.00 shares. The stock was down -0.73% to $1.36. It has fallen over the last 12 months, dropping -93.45% and marked new low $0.78. Affymax, Inc., a biopharmaceutical company, engages in discovering, developing, and delivering therapies that improve the lives of patients with kidney diseases, and other serious and life-threatening illnesses.
Will AFFY Get Buyers Even After The Recent Rally? Find Out Here
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)